Muscular Dystrophy Trial, Recruiting (NCT07609394)

Muscular Dystrophy Trial, Recruiting NCT07609394 Sponsor: The Duchenne Registry Condition: Muscular Dystrophy

Printed from Voxsanity (voxsanity.com.au) — NCT07609394 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Muscular Dystrophy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Duchenne muscular dystrophy, Becker muscular dystrophy, or you are a female carrier of one of these conditions
You are a patient at a healthcare facility that is already connected to PPMD's Interchange system through their electronic health records (EHR)
You are willing to give permission for your health records to be shared with the PPMD Interchange system, and linked to any existing registry information about you

Who may not be able to join:

You have a different type of muscular dystrophy that is not Duchenne or Becker
You are not willing to give consent to share your health records
People with severe mobility or strength difficulties, communication challenges, or intellectual disabilities may not be able to join without the help of a caregiver or a legally designated representative who can assist with the consent process (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ann Martin, MS, CGC, Parent Project Muscular Dystrophy

Phone: 800-714-5437

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07609394

Sponsor: The Duchenne Registry

Phase: Not Applicable

Status: Recruiting

Condition: Muscular Dystrophy

Trial contact: 800-714-5437

More information: https://clinicaltrials.gov/study/NCT07609394

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Duchenne muscular dystrophy, Becker muscular dystrophy, or you are a female carrier of one of these conditions
You are a patient at a healthcare facility that is already connected to PPMD's Interchange system through their electronic health records (EHR)
You are willing to give permission for your health records to be shared with the PPMD Interchange system, and linked to any existing registry information about you

Who may not be able to join:

You have a different type of muscular dystrophy that is not Duchenne or Becker
You are not willing to give consent to share your health records
People with severe mobility or strength difficulties, communication challenges, or intellectual disabilities may not be able to join without the help of a caregiver or a legally designated representative who can assist with the consent process (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The Duchenne Registry

Registry

ClinicalTrials.gov

Start date

1 December 2022

Est. completion

1 December 2035

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Progressive Muscle Weakness; Cardiac Function; Pulmonary Function; Bone Health

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov